Spineart and eCential Robotics Receive FDA Clearance for PERLA TL Spine App

August 26, 2026
Spineart and eCential Robotics received FDA 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotics platform.

Spineart and eCential Robotics said in a press release that the U.S. FDA granted 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotics platform.

The clearance adds robotic workflow use for PERLA TL, which was already compatible with the Op.n navigation platform. The system is intended to support placement of PERLA TL Open and MIS pedicle screw systems in open and minimally invasive spine procedures.

The PERLA app runs on the Op.n platform and combines Spineart implant technology with eCential Robotics navigation and robotic assistance. The companies said the app will be displayed at the Spineart Innovation Center in Dallas.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.

Subscribe to Robotics Brief

Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more